EndMT is a spectrum of phenotypic changes in ECs and whether inhibition of IL-1R1 mediated EndMT in atherosclerosis is yet to be investigated and future studies from our laboratory will focus on dissecting the downstream pathway(s) involved. Here, IL1R1 is linked to atherosclerosis.